MC
RMD icon

Martin Currie’s ResMed RMD Stock Holding History

Martin Currie’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$35.1M Sell
136,131
-4,803
-3% -$1.15M 1.35% 24
2025
Q1 		$31.5M Buy
140,934
+26,053
+23% +$6.08M 1.27% 27
2024
Q4 		$26.3M Sell
114,881
-15,646
-12% -$3.77M 0.97% 31
2024
Q3 		$31.4M Sell
130,527
-16,193
-11% -$3.62M 1.12% 23
2024
Q2 		$28.1M Sell
146,720
-158,712
-52% -$32.2M 1.01% 27
2024
Q1 		$60.5M Buy
305,432
+3,290
+1% +$603K 1.86% 19
2023
Q4 		$52M Sell
302,142
-26,349
-8% -$4.05M 1.71% 23
2023
Q3 		$48.6M Sell
328,491
-6,615
-2% -$1.2M 1.74% 22
2023
Q2 		$73.2M Buy
335,106
+285
+0.1% +$63.5K 2.46% 16
2023
Q1 		$73.3M Sell
334,821
-15,603
-4% -$3.39M 2.62% 15
2022
Q4 		$72.9M Sell
350,424
-21,389
-6% -$4.7M 2.85% 16
2022
Q3 		$81.2M Sell
371,813
-17,284
-4% -$3.93M 3.45% 12
2022
Q2 		$81.6M Sell
389,097
-3,994
-1% -$850K 3.16% 12
2022
Q1 		$95.3M Sell
393,091
-4,291
-1% -$1.04M 3.06% 13
2021
Q4 		$104M Sell
397,382
-25,923
-6% -$6.73M 2.87% 16
2021
Q3 		$112M Buy
423,305
+63,124
+18% +$17.3M 3.42% 13
2021
Q2 		$88.8M Sell
360,181
-2,780
-0.8% -$584K 3.06% 17
2021
Q1 		$70.4M Buy
362,961
+1,183
+0.3% +$237K 2.72% 16
2020
Q4 		$76.9M Buy
361,778
+172,855
+91% +$34.5M 2.83% 15
2020
Q3 		$32.4M Buy
188,923
+4,368
+2% +$807K 1.67% 22
2020
Q2 		$35.4M Sell
184,555
-5,607
-3% -$917K 2.18% 13
2020
Q1 		$28M Sell
190,162
-3,723
-2% -$593K 1.95% 11
2019
Q4 		$30.3M Buy
193,885
+23,393
+14% +$3.37M 1.68% 13
2019
Q3 		$23M Sell
170,492
-7,262
-4% -$951K 1.48% 18
2019
Q2 		$21.7M Buy
177,754
+8,603
+5% +$953K 1.55% 17
2019
Q1 		$17.6M Buy
+169,151
New +$17.5M 1.23% 23

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Martin Currie's RMD Position: Q2 2025 in Review

Martin Currie reduced its ResMed (RMD) stake by 3.4% in Q2 2025, selling an estimated $1.15M and leaving 136,131 shares worth $35.1M. The position accounts for 1.35% of the portfolio, ranked #24.

Martin Currie first reported a position in RMD in Q1 2019 and has held it in 26 quarters since. The position peaked at $112M in Q3 2021. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Martin Currie held 136,131 shares of ResMed worth $35.1M as of Q2 2025.
  • Martin Currie sold 4,803 ResMed shares in Q2 2025, an estimated $1.15M.
  • ResMed made up 1.35% of Martin Currie's portfolio in Q2 2025, its #24 holding.
  • Martin Currie first reported a position in ResMed in Q1 2019 and has held it in 26 quarters since.
  • Martin Currie's ResMed position peaked at $112M in Q3 2021.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Martin Currie's 13F filing for Q2 2025, filed 12 Aug 2025.